Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.

Komosinska K, Kepka L, Niwinska A, Pietrzak L, Wierzchowski M, Tyc-Szczepaniak D, Kaczmarczyk A, Bujko K.

Acta Oncol. 2010 Apr;49(3):382-8. doi: 10.3109/02841860903352942.

PMID:
20397770
2.

Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.

Wong J, Hird A, Zhang L, Tsao M, Sinclair E, Barnes E, Danjoux C, Chow E.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1125-31. doi: 10.1016/j.ijrobp.2008.12.013. Epub 2009 Feb 21.

PMID:
19231099
3.

Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.

Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, Schild SE, Dahm-Daphi J.

Strahlenther Onkol. 2008 Jan;184(1):30-5. doi: 10.1007/s00066-008-1795-5.

PMID:
18188520
4.

Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).

Rades D, Bohlen G, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Dunst J.

Strahlenther Onkol. 2007 Nov;183(11):631-6.

PMID:
17960339
5.
7.

Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).

Bohlen G, Meyners T, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Rades D.

Clin Neurol Neurosurg. 2010 Apr;112(3):183-7. doi: 10.1016/j.clineuro.2009.11.004. Epub 2009 Dec 3.

PMID:
19962229
8.

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.

Rades D, Lohynska R, Veninga T, Stalpers LJ, Schild SE.

Cancer. 2007 Dec 1;110(11):2587-92.

9.

Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?

Rades D, Heisterkamp C, Schild SE.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):398-403. doi: 10.1016/j.ijrobp.2009.08.022. Epub 2010 May 18.

PMID:
20488627
10.

Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.

Kocher M, Maarouf M, Bendel M, Voges J, Müller RP, Sturm V.

Strahlenther Onkol. 2004 May;180(5):263-7.

PMID:
15127155
11.

Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.

Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen-Solal C, De Lalande B, Moisson P, Breton-Callu C, Gardner M, Goupil A, Renody N, Floiras JL, Labib A.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):839-45. Epub 2007 Jun 4.

PMID:
17544592
12.
13.

Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.

Heisterkamp C, Haatanen T, Schild SE, Rades D.

Strahlenther Onkol. 2010 Feb;186(2):70-5. doi: 10.1007/s00066-010-2067-8. Epub 2010 Jan 26.

PMID:
20127223
14.

Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study.

Mahmoud-Ahmed AS, Suh JH, Lee SY, Crownover RL, Barnett GH.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):810-7.

PMID:
12377333
15.

Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study.

Cannady SB, Cavanaugh KA, Lee SY, Bukowski RM, Olencki TE, Stevens GH, Barnett GH, Suh JH.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):253-8.

PMID:
14697446
16.

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.

Nieder C, Andratschke N, Grosu AL, Molls M.

Strahlenther Onkol. 2003 Jan;179(1):16-20.

PMID:
12540980
17.

Prognostic factors affecting the outcome of brain metastases from breast cancer.

Liu MT, Hsieh CY, Wang AY, Chang TH, Pi CP, Huang CC, Huang CY, Liou CH.

Support Care Cancer. 2006 Sep;14(9):936-42. Epub 2006 Mar 31.

PMID:
16575571
19.

Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.

Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ, Dunst J.

Cancer. 2007 Sep 1;110(5):1077-82.

20.

A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.

Rades D, Dunst J, Schild SE.

Strahlenther Onkol. 2008 May;184(5):251-5. doi: 10.1007/s00066-008-1831-5.

PMID:
18427755

Supplemental Content

Support Center